Novo Nordisk A/S ADR (NY: NVO )

105.06 +2.43 (+2.37%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist

Other Filings

Form 6-K
Source: SEC/Edgar
May 13, 2018
Form 6-K
Source: SEC/Edgar
May 08, 2018
Form 6-K
Source: SEC/Edgar
May 07, 2018
Form 6-K
Source: SEC/Edgar
May 06, 2018
Form 6-K
Source: SEC/Edgar
May 06, 2018
Form 6-K
Source: SEC/Edgar
May 06, 2018
Form 6-K
Source: SEC/Edgar
May 06, 2018
Form 6-K
Source: SEC/Edgar
May 01, 2018
Form 6-K
Source: SEC/Edgar
April 30, 2018
Form 6-K
Source: SEC/Edgar
April 30, 2018
Form 6-K
Source: SEC/Edgar
April 24, 2018
Form 6-K
Source: SEC/Edgar
April 23, 2018
Form 6-K
Source: SEC/Edgar
April 22, 2018
Form 6-K
Source: SEC/Edgar
April 15, 2018
Form 6-K
Source: SEC/Edgar
April 08, 2018
Form 6-K
Source: SEC/Edgar
April 02, 2018
Form 6-K
Source: SEC/Edgar
April 02, 2018
Form 6-K
Source: SEC/Edgar
March 26, 2018
Form 6-K
Source: SEC/Edgar
March 19, 2018
Form 6-K
Source: SEC/Edgar
March 11, 2018
Form 6-K
Source: SEC/Edgar
March 04, 2018
Form 6-K
Source: SEC/Edgar
February 25, 2018
Form 6-K
Source: SEC/Edgar
February 25, 2018
Form 6-K
Source: SEC/Edgar
February 19, 2018
Form 6-K
Source: SEC/Edgar
February 13, 2018
Form 6-K
Source: SEC/Edgar
February 12, 2018
Form 6-K
Source: SEC/Edgar
February 12, 2018
Form 6-K
Source: SEC/Edgar
February 12, 2018
Form 6-K
Source: SEC/Edgar
February 08, 2018
Form 20-F
Source: SEC/Edgar
February 07, 2018
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.